Copyright
©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Mar 14, 2006; 12(10): 1591-1596
Published online Mar 14, 2006. doi: 10.3748/wjg.v12.i10.1591
Published online Mar 14, 2006. doi: 10.3748/wjg.v12.i10.1591
Anorectal parameter | Placebo | Sumatriptan |
Maximal resting pressure | 9.2 ± 2.0 kPa | 13.1 ± 3.3 kPab |
Sphincter length during rest | 4.0 ± 0.5 cm | 4.5 ± 0.4 cmb |
High pressure zone during rest | 2.6 ± 0.3 cm | 3.1 ± 0.5 cmb |
Sphincter length during squeeze | 5.1 ± 0.4 cm | 5.4 ± 0.5 cmb |
Urge sensation threshold | 61 ± 19 mL | 68 ± 18 mLb |
First sensation threshold | 27 ± 9 mL | 34 ± 12 mLc |
High pressure zone during squeeze | 2.8 ± 0.6 cm | 3.0 ± 0.7 cmc |
Pain threshold: ≤100mL/>100mL (number of patients) | 13/9 | 8/14 |
Rectoanal inhibitory reflex (RAIR) | 21 ± 8 mL | 21 ± 9 mL |
Straining test results: | ||
Proper relaxation/lack of relaxation/ contraction (number of patients) | 14/7/1 | 13/8/1 |
Maximal squeeze pressure | 25.5 ± 8.5 kPa | 27.2 ± 8.4 kPa |
Maximal cough pressure/maximal resting pressure | 2.9 ± 0.8 | 3.1 ± 1.1 |
- Citation: Mulak A, Paradowski L. Effect of 5-HT1 agonist (sumatriptan) on anorectal function in irritable bowel syndrome patients. World J Gastroenterol 2006; 12(10): 1591-1596
- URL: https://www.wjgnet.com/1007-9327/full/v12/i10/1591.htm
- DOI: https://dx.doi.org/10.3748/wjg.v12.i10.1591